What every Site and Sponsor needs to know.  This session will explain the rationale for the ICH GCP addendum E6 (R3); Unravel ICH E6 (R3) and master the future of clinical trials; Recognize the importance and impact of the changes for the sponsor/CRO and investigators/sites responsibilities.

MODERATOR

Erica Parks Murray - Manager - Clarkston Consulting

SPEAKER

Laurie Stone - Director - Clarkston Consulting